3 completed, 2 unknown, 1 not yet recruiting, 1 terminated. 3 Phase 2, 2 Phase 1, 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Unknown 2 |
| Not applicable | 1 | Completed 1 |
Follow Acetylglucosamine: new trials by email Literature Review of Acetylglucosamine trials Research Report on Acetylglucosamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral N-acetylglucosamine in Crohn's Disease N-Acetylglucosamine (GlcNAc) - Crohns Disease | Phase 2 | Not yet recruiting | Johns Hopkins University | 40 | 2027-01-05 | 2026-11-05 |
| Effect of Hyaluronic Acid Oral Supplementation on Sexual and Urinary Symptoms of Women With Recurrent Urinary Tract Infections HA 100 mg, CS 400 mg, N-Acetylglucosamine 200 mg and vitamin C 80 mg + cranberry, D-mannose, propolis extract, tumeric and Boswellia, cranberry, D-mannose, propolis extract, tumeric and Boswellia - Urinary Tract Infections, Recurrent | Not applicable | Completed | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 50 | 2022-03-01 | 2024-02-20 |
| N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) N-acetyl glucosamine (NAG), Control - Coronavirus, Covid19 | Phase 1 | Completed | Quantinosis.ai LLC | 150 | 2020-11-14 | 2023-04-04 |
| Therapeutic Approaches to Malnutrition Enteropathy Colostrum high protein powder (Neovite), N-Acetyl Glucosamine (GInNAC), Teduglutide - Severe Acute Malnutrition | Phase 2 | Completed | Queen Mary University of London | 125 | 2020-05-04 | 2021-09-27 |
| Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation N-Acetylglucosamine (GlcNAc), Uridine - PGM3 | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 2 | 2015-06-30 | 2017-07-02 |
| Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment Starch Placebo, N-acetyl-D-glucosamine - Irritable Bowel Syndrome | Phase 3 | Unknown | Third Military Medical University | 720 | 2015-06-01 | 2015-07-21 |
| Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment N-acetyl-D-glucosamine, placebo - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Unknown | Third Military Medical University | 180 | 2013-04-01 | 2015-07-24 |
Abdominal Pain (2) · Diarrhea (2) · Irritable Bowel Syndrome (2) · COVID-19 (1) · Coronavirus Infections (1) · Crohn Disease (1) · Severe Acute Malnutrition (1) · Urinary Tract Infections (1)
Third Military Medical University (2) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Johns Hopkins University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Quantinosis.ai LLC (1) · Queen Mary University of London (1)
United States (3) · China (2) · Italy (1) · Zambia (1) · Zimbabwe (1)
Junkang Liu, Doctor (2) · Andrew Prendergast, PhD (1) · Beatrice Amadi, MD (1) · Joanna Melia, MD (1) · Jonathan J Lyons, M.D. (1) · Mutsa Bwakura-Dangarembizi, MB (1) · Paul Kelly, MD (1)
PMID 31727642, PMID 34306677, PMID 38632262, PMID 38721680
R01DK141870 (1)